Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News VIVA 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

L.A. McKeown

November 03, 2023

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

Social Factors Contribute to Race Differences in Premature CVD: CARDIA

Yael L. Maxwell

May 30, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

Yael L. Maxwell

September 20, 2019

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

Shelley Wood

September 30, 2017

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Todd Neale

September 15, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

News Daily News

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

L.A. McKeown

May 03, 2017

Advertisement

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

Social Factors Contribute to Race Differences in Premature CVD: CARDIA

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

TCTMD’s Top 10 Most Popular Stories for January 2018

TCTMD’s Top 10 Most Popular Stories for September 2017

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

TCTMD’s Top 10 Most Popular Stories for August 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content